Form D · Biotechnology

Amplifi Vascular, Inc.

Prairie Village, KS · CIK 0001990753

Offering snapshot reported Jun 30, 2026 · SEC filing

Reported sold: $5.96M
Investors reported: 59
Minimum accepted: $0
First sale: Aug 21, 2024

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$5,910,278 → $5,960,278

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jun 30, 2026	Amendment	$5,960,278	$50,000vs Mar 26, 2026	59	SEC filing
Mar 26, 2026	Amendment	$5,910,278	$4,366,659vs Nov 27, 2024	59	SEC filing
Nov 27, 2024	Initial	$1,543,619	No comparison	23	SEC filing
Jun 25, 2024	Amendment	$808,000	$250,000vs Aug 21, 2023	6	SEC filing
Aug 21, 2023	Initial	$558,000	No comparison	4	SEC filing

Offering details

Securities: Debt, Option to acquire
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0 (estimated)
Finders' fees: $0 (estimated)
Form D file number: 021-530724

Source: Form D, filed Jun 30, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Steve Braun	Director
Nathaniel Hagedorn	Director
Sean Morris	Director, Executive
James Schultz	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

3965 West 83rd Street, #300
Prairie Village, KS, 66208
Phone: 913-730-0175